[1]Lozzio CB, Lozzio BB. Human chronic myelogenous leukemia cell-line with positive philadelphia chromosome[J]. Blood, 1975, 45(3): 321-334.
[2]Huo XF, Yu J, Peng H, et al. Differential expression changes in k562 cells during the hemin-induced erythroid differentiation and the phorbol myristate acetate (pma)-induced megakaryocytic differentiation[J]. Mol Cell Biochem, 2006, 292(1-2): 155-167.
[3]Nakajima O, Iwasaki S, Hashimoto Y. Hemin-induced erythroid differentiation of human myeloleukemia K562 cell line and its modification by bioresponse modifiers[J]. Cell Mol Biol, 1997, 43(1): 115-134.
[4]Witt O, Sand K, Pekrun A. Butyrate-induced erythroid differentiation of human k562 leukemia cells involves inhibition of erk and activation of p38 map kinase pathways[J]. Blood, 2000, 95(7): 2391-2396.
[5]Kamano H, Tanaka T, Ohnishi H, et al. Effects of the antisense myb expression on hemin-and erythropoietin-induced erythroid differentiation of k562 cells[J]. Biochem Mol Biol Int, 1994, 34(1): 85-92.
[6]Woon Kim Y, Kim S, Geun Kim C, et al. The distinctive roles of erythroid specific activator gata-1 and nf-e2 in transcription of the human fetal gamma-globin genes[J]. Nucleic Acids Res, 2011, 39(16): 6944-6955.
[7]Chan JY, Han XL, Kan YW. Isolation of cdna encoding the human nf-e2 protein[J]. Proce Nati Acad Sci USA, 1993, 90(23): 11366-11370.
[8]Lento W, Congdon K, Voermans C, et al. Wnt signaling in normal and malignant hematopoiesis[J]. Cold Spring Harb Perspect Biol, 2013, 5(2): 1-10
[9]Wolda SL, Moon RT. Cloning and developmental expression in xenopus laevis of seven additional members of the wnt family[J]. Oncogene, 1992, 7(10): 1941-1947.
[10]Kelly GM, Lai CJ, Moon RT. Expression of wnt10a in the central nervous system of developing zebrafish[J]. Dev Biol, 1993, 158(1): 113-121.
[11]Gelebart P, Anand M, Armanious H, et al. Constitutive activation of the wnt canonical pathway in mantle cell lymphoma[J]. Blood, 2008, 112(13): 5171-5179.
[12]Bohring A, Stamm T, Spaich C, et al. WNT10A mutations are a frequent cause of a broad spectrum of ectodermal dysplasias with sex-biased manifestation pattern in heterozygotes[J]. Am J Hum Genet, 2009, 85(1): 97-105.
[13]Logan CY, Nusse R. The Wnt signaling pathway in development and disease[J]. Annu Rev Cell Dev Biol, 2004, 20(1)781-810.
[14]Gao B, Song H, Bishop K, et al. Wnt signaling gradients establish planar cell polarity by inducing vangl2 phosphorylation through ror2[J]. Dev Cell, 2011, 20(2): 163-176.
[15]Montcouquiol M, Crenshaw EB, Kelley MW. Noncanonical wnt signaling and neural polarity[J]. Ann Rev Neurosci, 2006, 29(1)363-386.
[16]Austin TW, Solar GP, Ziegler FC, et al. A role for the wnt gene family in hematopoiesis: expansion of multilineage progenitor cells[J]. Blood, 1997, 89(10): 3624-3635.
[17]Tran HT, Sekkali B, Van Imschoot G, et al. Wnt/beta-catenin signaling is involved in the induction and maintenance of primitive hematopoiesis in the vertebrate embryo[J]. Proc Nati Acad Sci USA, 2010, 107(37): 16160-16165.
[18]Van Den Berg DJ, Sharma AK, Bruno E, et al. Role of members of the wnt gene family in human hematopoiesis[J]. Blood, 1998, 92(9): 3189-3202.
[19]Dijksterhuis JP, Petersen J, Schulte G. Wnt/frizzled signalling: Receptor-ligand selectivity with focus on fzd-g protein signalling and its physiological relevance: Iuphar review 3[J]. Br J Pharmacol, 2014, 171(5): 1195-1209.
[20]Miller JR. The Wnts[J]. Genome Biol, 2002, 3(1): REVIEWS3001. Epub 2001 Dec 28.
[21]Plaisancie J, Bailleul-Forestier I, Gaston V, et al. Mutations in WNT10A are frequently involved in oligodontia associated with minor signs of ectodermal dysplasia[J]. Am J Med Gene A, 2013, 161A(4): 671-678.
[22]Vink CP, Ockeloen CW, ten Kate S, et al. Variability in dentofacial phenotypes in four families with wnt10a mutations[J]. Eur J Hum Genet, 2014, 22(9): 1063-1070. |